Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
0.00%
)
Bitcoin
78,376.56
(
-0.86%
)
News Focus
News Focus
Post# of 257579
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 207538

Wednesday, 01/04/2017 8:05:03 PM

Wednesday, January 04, 2017 8:05:03 PM

Post# of 257579
GILD—A deep insight from Jefferies:

http://blogs.barrons.com/stockstowatchtoday/2017/01/04/gilead-sciences-with-new-hire-ma-might-be-on-the-way

We believe the relatively high-profile heme/onc chief hire signals an increasing focus in oncology…and expect Gilead Sciences to more aggressively pursue business development to build out a broader cancer pipeline…

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today